Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-07-01 Sale |
2021-07-06 6:02 pm |
Keros Therapeutics Inc. | KROS | Knowles Julius Director |
47,652 | $41.31 | $1,968,352 | 345,585 (Indirect) |
View |
| 2021-06-11 Sale |
2021-06-15 5:02 pm |
Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer |
2,650 | $50.98 | $135,087 | 207,612 (Direct) |
View |
| 2021-06-11 Sale |
2021-06-15 5:01 pm |
Keros Therapeutics Inc. | KROS | Ordonez Claudia Chief Medical Officer |
1,000 | $50.99 | $50,990 | 98,211 (Direct) |
View |
| 2021-06-04 Sale |
2021-06-08 4:31 pm |
Keros Therapeutics Inc. | KROS | Knowles Julius Director |
19,415 | $49.07 | $952,613 | 364,395 (Indirect) |
View |
| 2021-06-01 Sale |
2021-06-03 8:06 pm |
Keros Therapeutics Inc. | KROS | Knowles Julius Director |
28,236 | $49.71 | $1,403,553 | 372,059 (Indirect) |
View |
| 2021-05-11 Sale |
2021-05-13 4:37 pm |
Keros Therapeutics Inc. | KROS | Ordonez Claudia Chief Medical Officer |
1,000 | $50.15 | $50,150 | 99,211 (Direct) |
View |
| 2021-05-11 Sale |
2021-05-13 4:36 pm |
Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer |
2,650 | $50 | $132,500 | 218,055 (Direct) |
View |
| 2021-05-03 Sale |
2021-05-05 5:22 pm |
Keros Therapeutics Inc. | KROS | Knowles Julius Director |
47,651 | $57.27 | $2,728,849 | 383,205 (Indirect) |
View |
| 2021-04-12 Sale |
2021-04-14 4:46 pm |
Keros Therapeutics Inc. | KROS | Ordonez Claudia Chief Medical Officer |
1,000 | $59.93 | $59,926 | 100,211 (Direct) |
View |
| 2021-04-12 Sale |
2021-04-14 4:43 pm |
Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer |
5,300 | $60 | $318,026 | 206,192 (Direct) |
View |
| 2021-04-06 Sale |
2021-04-08 4:35 pm |
Keros Therapeutics Inc. | KROS | Knowles Julius Director |
9,298 | $58.81 | $546,840 | 402,015 (Indirect) |
View |
| 2021-04-01 Sale |
2021-04-05 9:11 pm |
Keros Therapeutics Inc. | KROS | Knowles Julius Director |
38,353 | $59.72 | $2,290,536 | 405,685 (Indirect) |
View |
| 2021-03-11 Sale |
2021-03-15 4:45 pm |
Keros Therapeutics Inc. | KROS | Ordonez Claudia Chief Medical Officer |
1,000 | $64.56 | $64,556 | 101,211 (Direct) |
View |
| 2021-03-11 Sale |
2021-03-15 4:43 pm |
Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer |
5,300 | $64.48 | $341,750 | 201,496 (Direct) |
View |
| 2021-03-03 Sale |
2021-03-05 7:44 pm |
Keros Therapeutics Inc. | KROS | Knowles Julius Director |
23,959 | $56.45 | $1,352,499 | 420,825 (Indirect) |
View |
| 2021-03-01 Sale |
2021-03-03 8:40 pm |
Keros Therapeutics Inc. | KROS | Knowles Julius Director |
23,690 | $61.13 | $1,448,078 | 430,283 (Indirect) |
View |
| 2021-02-16 Sale |
2021-02-18 6:46 pm |
Keros Therapeutics Inc. | KROS | Knowles Julius Director |
28,617 | $60.87 | $1,742,043 | 439,634 (Indirect) |
View |
| 2021-02-11 Sale |
2021-02-16 5:50 pm |
Keros Therapeutics Inc. | KROS | Knowles Julius Director |
19,029 | $63.53 | $1,208,936 | 450,930 (Indirect) |
View |
| 2021-02-11 Sale |
2021-02-16 5:49 pm |
Keros Therapeutics Inc. | KROS | Ordonez Claudia Chief Medical Officer |
1,000 | $64.84 | $64,841 | 102,211 (Direct) |
View |
| 2021-02-11 Sale |
2021-02-16 5:47 pm |
Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer |
5,300 | $64.91 | $344,017 | 173,596 (Direct) |
View |
| 2020-11-17 Purchase |
2020-11-19 4:40 pm |
Keros Therapeutics Inc. | KROS | Nussbaum Ran Pontifax (Israel) IV L.P. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax Late Stage Fund L.P. Pontifax Late Stage GP Ltd. Director 10% Owner |
60,000 | $50 | $3,000,000 | 155,262 (Indirect) |
View |
| 2020-11-17 Purchase |
2020-11-19 4:39 pm |
Keros Therapeutics Inc. | KROS | Kariv Tomer Pontifax (Israel) IV L.P. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax Late Stage Fund L.P. Pontifax Late Stage GP Ltd. Director 10% Owner |
60,000 | $50 | $3,000,000 | 155,262 (Indirect) |
View |
| 2020-11-17 Purchase |
2020-11-19 4:38 pm |
Keros Therapeutics Inc. | KROS | Pontifax Management 4 G.P. (2015) Ltd. Pontifax (Israel) IV L.P. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax Late Stage Fund L.P. Pontifax Late Stage GP Ltd. 10% Owner |
60,000 | $50 | $3,000,000 | 155,262 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-08-10 Option Award |
2021-08-11 4:56 pm |
N/A 2031-08-09 |
Keros Therapeutics Inc. | KROS | Cooper Simon Peter Chief Medical Officer |
60,000 | $0 | 60,000 (Direct) |
View |
| 2021-06-24 Exercise |
2021-06-25 6:29 pm |
N/A 2028-03-25 |
Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer |
6,500 | $0 | 85,700 (Direct) |
View |
| 2021-06-24 Exercise |
2021-06-25 6:29 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer |
6,500 | $0.3 | 85,700 (Direct) |
View |
| 2021-06-11 Exercise |
2021-06-15 5:02 pm |
N/A 2028-03-25 |
Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer |
2,650 | $0 | 207,612 (Direct) |
View |
| 2021-06-11 Exercise |
2021-06-15 5:02 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer |
2,650 | $0.3 | 207,612 (Direct) |
View |
| 2021-06-11 Exercise |
2021-06-15 5:01 pm |
N/A 2029-09-18 |
Keros Therapeutics Inc. | KROS | Ordonez Claudia Chief Medical Officer |
1,000 | $0 | 98,211 (Direct) |
View |
| 2021-06-11 Exercise |
2021-06-15 5:01 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Ordonez Claudia Chief Medical Officer |
1,000 | $0.48 | 98,211 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:34 pm |
N/A 2031-05-31 |
Keros Therapeutics Inc. | KROS | Nussbaum Ran Director 10% Owner |
8,293 | $0 | 8,293 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:33 pm |
N/A 2031-05-31 |
Keros Therapeutics Inc. | KROS | Knowles Julius Director |
8,293 | $0 | 8,293 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:31 pm |
N/A 2031-05-31 |
Keros Therapeutics Inc. | KROS | Kariv Tomer Director 10% Owner |
8,293 | $0 | 8,293 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:30 pm |
N/A 2031-05-31 |
Keros Therapeutics Inc. | KROS | GRAY MARY ANN Director |
8,293 | $0 | 8,293 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:29 pm |
N/A 2031-05-31 |
Keros Therapeutics Inc. | KROS | Farzan Nima Director |
8,293 | $0 | 8,293 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:27 pm |
N/A 2031-05-31 |
Keros Therapeutics Inc. | KROS | GORDON CARL L Director |
8,293 | $0 | 8,293 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 4:37 pm |
N/A 2029-09-18 |
Keros Therapeutics Inc. | KROS | Ordonez Claudia Chief Medical Officer |
1,000 | $0 | 99,211 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 4:37 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Ordonez Claudia Chief Medical Officer |
1,000 | $0.48 | 99,211 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 4:36 pm |
N/A 2028-03-25 |
Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer |
9,370 | $0 | 218,055 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 4:36 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer |
3,150 | $0.3 | 218,055 (Direct) |
View |
| 2021-05-13 Exercise |
2021-05-13 4:36 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer |
6,220 | $0.11 | 218,055 (Direct) |
View |
| 2021-04-12 Exercise |
2021-04-14 4:46 pm |
N/A 2029-09-18 |
Keros Therapeutics Inc. | KROS | Ordonez Claudia Chief Medical Officer |
1,000 | $0 | 100,211 (Direct) |
View |
| 2021-04-12 Exercise |
2021-04-14 4:46 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Ordonez Claudia Chief Medical Officer |
1,000 | $0.48 | 100,211 (Direct) |
View |
| 2021-04-12 Exercise |
2021-04-14 4:43 pm |
N/A 2028-03-25 |
Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer |
5,300 | $0 | 206,192 (Direct) |
View |
| 2021-04-12 Exercise |
2021-04-14 4:43 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer |
5,300 | $0.3 | 206,192 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-02 4:32 pm |
N/A 2027-02-05 |
Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer |
9,996 | $0 | 71,187 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-02 4:32 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer |
9,996 | $0.11 | 71,187 (Direct) |
View |
| 2021-03-11 Exercise |
2021-03-15 4:45 pm |
N/A 2029-09-18 |
Keros Therapeutics Inc. | KROS | Ordonez Claudia Chief Medical Officer |
1,000 | $0 | 101,211 (Direct) |
View |
| 2021-03-11 Exercise |
2021-03-15 4:45 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Ordonez Claudia Chief Medical Officer |
1,000 | $0.48 | 101,211 (Direct) |
View |
| 2021-03-11 Exercise |
2021-03-15 4:43 pm |
N/A 2028-03-25 |
Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer |
5,300 | $0 | 201,496 (Direct) |
View |
| 2021-03-11 Exercise |
2021-03-15 4:43 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer |
5,300 | $0.3 | 201,496 (Direct) |
View |
| 2021-02-26 Exercise |
2021-03-01 4:54 pm |
N/A 2027-02-05 |
Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer |
33,200 | $0 | 71,187 (Direct) |
View |
| 2021-02-26 Exercise |
2021-03-01 4:54 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer |
33,200 | $0.11 | 71,187 (Direct) |
View |
| 2021-02-11 Exercise |
2021-02-16 5:49 pm |
N/A 2029-09-18 |
Keros Therapeutics Inc. | KROS | Ordonez Claudia Chief Medical Officer |
1,000 | $0 | 102,211 (Direct) |
View |
| 2021-02-11 Exercise |
2021-02-16 5:49 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Ordonez Claudia Chief Medical Officer |
1,000 | $0.48 | 102,211 (Direct) |
View |
| 2021-02-11 Exercise |
2021-02-16 5:47 pm |
N/A 2028-03-25 |
Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer |
5,300 | $0 | 173,596 (Direct) |
View |
| 2021-02-11 Exercise |
2021-02-16 5:47 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer |
5,300 | $0.3 | 173,596 (Direct) |
View |
| 2021-01-10 Option Award |
2021-01-12 5:25 pm |
N/A 2031-01-09 |
Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer |
49,150 | $0 | 49,150 (Direct) |
View |
| 2021-01-10 Option Award |
2021-01-12 5:23 pm |
N/A 2031-01-09 |
Keros Therapeutics Inc. | KROS | Ordonez Claudia Chief Medical Officer |
42,250 | $0 | 42,250 (Direct) |
View |
| 2021-01-10 Option Award |
2021-01-12 5:21 pm |
N/A 2031-01-09 |
Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer |
42,250 | $0 | 42,250 (Direct) |
View |
| 2021-01-10 Option Award |
2021-01-12 5:20 pm |
N/A 2031-01-09 |
Keros Therapeutics Inc. | KROS | Seehra Jasbir Chief Executive Officer |
127,200 | $0 | 127,200 (Direct) |
View |
| 2020-12-17 Option Award |
2020-12-21 4:43 pm |
N/A 2030-12-16 |
Keros Therapeutics Inc. | KROS | GRAY MARY ANN Director |
16,587 | $0 | 16,587 (Direct) |
View |